Evidence map›Paper›PMID 29155857›Full record

ArticlePloS one2017

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.

Elena Arystarkhova, Richard Bouley, Yi Bessie Liu, Kathleen J Sweadner

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. FXYD proteins and sodium pump regulatory mechanisms.The Journal of general physiology · 2021
    Review
  6. The role of AMPK in regulation of NaJournal of muscle research and cell motility · 2021
    Review
  7. Article
  8. Article
  9. Mammalian urine concentration: a review of renal medullary architecture and membrane transporters.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elena ArystarkhovaLaboratory of Membrane Biology, Dept. of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, Unites States of America.
Richard BouleyCenter for Systems Biology, Program in Membrane Biology and Division of Nephrology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Yi Bessie LiuLaboratory of Membrane Biology, Dept. of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, Unites States of America.
Kathleen J SweadnerLaboratory of Membrane Biology, Dept. of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, Unites States of America.ORCID http://orcid.org/0000-0002-2817-5262
Harvard University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Cell Biology of Vasopressin-induced Water Channels-Research SupplementR01DK096586 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Dennis Brown · 2012 to 2026
$7.3M
Cellular/molecular Na,K-ATPase regulation in choroid plexusR01NS050696 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SWEADNER, KATHLEEN J · 2007 to 2010
$1.4M
A Nikon A1R Confocal Microscope SystemS10RR031563 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2011 to 2011
$561k
Novel Target for Ciliary Epithelium Transport RegulationR03EY014390 · NEI · MASSACHUSETTS GENERAL HOSPITAL · PI SWEADNER, KATHLEEN J · 2003 to 2005
$519k
New Modulators of Na, K-ATPase in the CNSR21NS045083 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SWEADNER, KATHLEEN J · 2003 to 2004
$411k
NCRR NIH HHS S10 RR031563NEI NIH HHS R03 EY014390NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521NIDDK NIH HHS R01 DK096586NINDS NIH HHS R01 NS050696NINDS NIH HHS R21 NS045083
6 · The paper itself

Abstract

The final adjustment of urine volume occurs in the inner medullary collecting duct (IMCD), chiefly mediated by the water channel aquaporin 2 (AQP2). With vasopressin stimulation, AQP2 accumulation in the apical plasma membrane of principal cells allows water reabsorption from the lumen. We report that FXYD1 (phospholemman), better known as a regulator of Na,K-ATPase, has a role in AQP2 trafficking. Daytime urine of Fxyd1 knockout mice was more dilute than WT despite similar serum vasopressin, but both genotypes could concentrate urine during water deprivation. FXYD1 was found in IMCD. In WT mice, phosphorylated FXYD1 was detected intracellularly, and vasopressin induced its dephosphorylation. We tested the hypothesis that the dilute urine in knockouts was caused by alteration of AQP2 trafficking. In WT mice at baseline, FXYD1 and AQP2 were not strongly co-localized, but elevation of vasopressin produced translocation of both FXYD1 and AQP2 to the apical plasma membrane. In kidney slices, baseline AQP2 distribution was more scattered in the Fxyd1 knockout than in WT. Apical recruitment of AQP2 occurred in vasopressin-treated Fxyd1 knockout slices, but upon vasopressin washout, there was more rapid reversal of apical AQP2 localization and more heterogeneous cytoplasmic distribution of AQP2. Notably, in sucrose gradients, AQP2 was present in a detergent-resistant membrane domain that had lower sedimentation density in the knockout than in WT, and vasopressin treatment normalized its density. We propose that FXYD1 plays a role in regulating AQP2 retention in apical membrane, and that this involves transfers between raft-like membrane domains in endosomes and plasma membranes.

Indexed as

AnimalsAquaporin 2Centrifugation, Density GradientEndosomesEpithelial CellsFemaleGene Expression RegulationKidney MedullaKidney Tubules, CollectingMaleMembrane MicrodomainsMembrane ProteinsMiceMice, KnockoutMicrotomyPhosphoproteinsAqp2 protein, mouseAquaporin 2Membrane ProteinsphospholemmanPhosphoproteinsSucroseVasopressins

Identifiers

PMID29155857
PMCPMC5695786
OpenAlexW2768761539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.